SUN PHARMACEUTICAL IND L vs WANBURY LIMITED
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and WANBURY LIMITED (WANBURY) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs WANBURY on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability22
- Growth10
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Company has delivered good profit growth of 47.8% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 82.6%"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of 10.6% over past five years.", "Tax rate seems low", "Promoters have pledged 62.2% of their holding."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.